Choksi Labs Q1 FY27 PAT up 51% YoY at Rs 58 lakh

Pat Growth 25pctExceptional ItemResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.1%Reaction day

₹117.85

prior close

₹115.95

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.2%-0.1% vs market

Healthcare Service Provider peers, median of 26sector+0.4%-0.3% vs sector

On the reaction day the stock moved 0.1 pts less than Nifty Microcap 250 and 0.3 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.1+0.2-0.1+0.4-0.3

Next day

+5.0+0.2+4.8-2.1+7.1

+10.3+0.4+9.9-0.8+11.1

+15.7+0.7+15.0-1.8+17.6

+12.0+0.1+11.9-3.2+15.3

+11.2+0.7+10.6-1.5+12.7

+16.9+1.2+15.7-0.7+17.6

15d

+41.2+0.7+40.5-1.0+42.2

+69.7-1.2+70.9-0.9+70.6

+71.4-1.1+72.5-5.7+77.1

—————

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 26Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Choksi Laboratories posted Q1 FY27 revenue of Rs 1,207.89 lakh, up 7.4% YoY from Rs 1,124.52 lakh. Net profit rose to Rs 58.24 lakh from Rs 38.50 lakh, a 51% jump. EPS stood at Rs 0.84 vs Rs 0.55 last year. Total expenses climbed 8.1% to Rs 1,147.96 lakh. Auditor review report carries no qualification. Board approved results on 13 August 2026.

Likely market impact

Strong profit growth on modest revenue rise signals margin improvement; clean auditor report is positive.